Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccines

Infection and Immunity

Volumn 68, Issue 3, 2000, Pages 1109-1115

  Sydenham, Mark ^a   Douce, Gillian ^a   Bowe, Frances ^a   Ahmed, Saddif ^a   Chatfield, Steve ^a,b   Dougan, Gordon ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN; LIVE VACCINE; SALMONELLOSIS VACCINE; TETANUS TOXIN;

ADOLESCENT; ANIMAL MODEL; ARTICLE; BACTERIUM MUTANT; CELL ADHESION; CELL INVASION; DELETION MUTANT; FEMALE; GENE INSERTION; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; IMMUNIZATION; MICROBIAL ATTENUATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CARRIER PROTEINS; DNA TRANSPOSABLE ELEMENTS; FEMALE; IMMUNIZATION; MICE; MICE, INBRED BALB C; MUTATION; PEPTIDYLPROLYL ISOMERASE; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; VACCINES, INACTIVATED;

EID: 0033953691     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.3.1109-1115.2000     Document Type: Article

References (43)

1. Andresson, O. S., and J. E. Davies. 1980. Isolation and characterisation of lambda transducing phages for the E. coli genes ksgA and pdxA. Mol. Gen. Genet. 179:201-209.
2. + for all three chromosomally located systems of DNA restriction and modification. J. Bacteriol. 156:471-474.
3. Charles, I., and G. Dougan. 1990. Gene expression and the development of live enteric vaccines. Trends Biotechnol. 8:117-121.
4. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Bio/ Technology 10:888-892.
5. Chatfield, S. N., K. Strahan, D. Pickard, I. G. Charles, C. E. Hormaeche, and G. Dougan. 1992. Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microb. Pathog. 12:145-151.
6. Collins, F. M. 1974. Vaccines and cell-mediated immunity. Bacteriol. Rev. 38:371-402.
7. Cooper, G. L., L. M. Venables, R. A. Nicholas, G. A. Cullen, and C. E. Hormaeche. 1992. Vaccination of chickens with chicken-derived Salmonella enteritidis phage type 4 aroA live oral Salmonella vaccines. Vaccine 10:247-254.
8. Curtiss, R., III, and S. M. Kelly. 1987. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun. 55:3035-3043.
9. Dartigalongue, C., and S. Raina. 1998. A new heat-shock gene, ppiD, encodes a peptidyl-prolyl isomerase required for folding of outer membrane proteins in Escherichia coli. EMBO J. 17:3968-3980.
10. Dorman, C. J., S. Chatfield, C. F. Higgins, C. Hayward, and G. Dougan. 1989. Characterisation of porin and ompR mutants of a virulent strain of Salmonella typhimurium: ompR mutants are attenuated in vivo. Infect. Immun. 57:2136-2140.
11. Fairweather, N. F., S. N. Chatfield, A. J. Makoff, R. A. Strugnell, J. Bester, D. J. Maskell, and G. Dougan. 1990. Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier. Infect. Immun. 58:1323-1329.
12. Finlay, B. B. 1994. Molecular and cellular mechanisms of Salmonella pathogenesis. Curr. Top. Microbiol. 192:163-185.
13. Hensel, M., J. E. Shea, C. Gleeson, M. D. Jones, E. Dalton, and D. W. Holden. 1995. Simultaneous identification of bacterial virulence genes by negative selection. Science 269:400-403.
14. Hoiseth, S. K., and B. A. D. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-240.
15. Hone, D. M., A. M. Harris, S. Chatfield, G. Dougan, and M. M. Levine. 1991. Construction of genetically defined double aro mutants of Salmonella typhi. Vaccine 9:810-816.
16. Hone, D. M., C. O. Tacket, A. M. Harris, B. Kay, G. Losonsky, and M. M. Levine. 1992. Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine. J. Clin. Investig. 90:412-420.
17. Hormaeche, C. E. 1979. Natural resistance to Salmonella typhimurium in different inbred mouse strains. Immunology 37:311-318.
18. Jones, P. W., G. Dougan, C. Hayward, N. Mackensie, P. Collins, and S. N. Chatfield. 1990. Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium. Vaccine 9:29-36.
19. Lazar, S. W., M. Almiron, A. Tormo, and R. Kolter. 1998. Role of the Escherichia coli SurA protein in stationary-phase survival. J. Bacteriol. 180: 5704-5711.
20. Lazar, S. W., and R. Kolter. 1996. SurA assists the folding of Escherichia coli outer membrane proteins. J. Bacteriol. 178:1770-1773.
21. Levine, M. M., D. Herrington, J. R. Murphy, J. G. Morris, G. Losonsky, B. Tall, A. A. Lindberg, S. Svenson, S. Baqar, M. F. Edwards, and B. Stocker. 1987. Safety, infectivity, immunogenicity, and in vivo stability of two attenuate auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J. Clin. Investig. 79:888-902.
22. Mahan, M. J., J. M. Slauch, and J. J. Mekalanos. 1993. Selection of bacterial virulence genes that are specifically induced in hose tissues. Science 259: 686-688.
23. Miles, A. A., S. S. Misra, and J. O. Irwin. 1938. The estimation of the bactericidal power of the blood. J. Hyg. 39:732-749.
24. Miller, I., D. Maskell, C. Hormaeche, K. Johnson, D. Pickard, and G. Dougan. 1989. Isolation of orally attenuated Salmonella typhimurium following TnphoA mutagenesis. Infect. Immun. 57:2758-2763.
25. Miller, I. A., S. Chatfield, G. Dougan, L. DeSilva, H. S. Joysey, and C. Hormaeche. 1989. Bacteriophage P22 as a vehicle for transducing cosmid gene banks between smooth strains of Salmonella typhimurium: use in identifying a role for aroD in attenuating virulent Salmonella strains. Mol. Gen. Genet. 215:312-316.
26. Miller, S. I., J. J. Mekalanos, and W. S. Pulkkinen. 1990. Salmonella vaccines with mutations in the phoP virulence regulon. Res. Microbiol. 141:817-821.
27. Miller, V. L., and J. J. Mekalanos. 1988. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins an virulence determinants in Vibrio cholerae requires toxR. J. Bacteriol. 170:2575-2583.
28. Missiakes, D., J. M. Betton, and S. Raina. 1996. New components of protein folding in extracytoplasmid compartments of Escherichia coli surA, FkpA and Skp/OmpH. Mol. Microbiol. 21:871-884.
29. Mukkur, T. K. S., G. N. McDowell, B. A. D. Stocker, and A. K. Lascelles. 1987. Protection against salmonellosis in mice and sheep by immunisation with aromatic-dependent Salmonella typhimurium. J. Med. Microbiol. 24:11-19.
30. O'Callaghan, D., D. Maskell, F. V. Liew, C. S. F. Easmon, and G. Dougan. 1988. Characterization of aromatic-and purine-dependent Salmonella typhimurium: attenuation, persistence, and ability to induce protective immunity in BALB/c mice. Infect. Immun. 56:419-426.
31. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
32. Roberts, M., L. J. Li, A. Bacon, and S. N. Chatfield. 1998. Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters. Infect. Immun. 66:3080-3087.
33. Rouviere, P. E., and C. A. Gross. 1996. SurA, a periplasmic protein with peptidyl-prolyl isomerase activity, participates in the assembly of outer membrane proteins. Genes Dev. 10:3170-3182.
34. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
35. Small, P. L. C., R. R. Isberg, and S. Falkow. 1987. Comparison of the ability of enteroinvasive Escherichia coli, Salmonella typhimurium, Yersinia pseudo-tuberculosis, and Yersinia enterocolitica to enter and replicate within HEp-2 cells. Infect. Immun. 55:1674-1679.
36. Stoker, N. G., N. F. Fairweather, and B. G. Spratt. 1982. Versatile low-copy-number plasmid vectors for cloning in Escherichia coli. Gene 18:335-341.
37. Tacket, C. O., D. M. Hone, R. Curtiss III, S. M. Kelly, G. Losonsky, L. Guers, A. M. Harris, R. Edelman, and M. M. Levine. 1992. Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers. Infect. Immun. 60:536-541.
38. Tacket, C. O., D. M. Hone, G. A. Losoonsky, L. Guers, R. Edelman, and M. M. Levine. 1992. Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain. Vaccine 10:443-450.
39. Tacket, C. O., M. B. Sztein, G. A. Losonsky, S. S. Wasserman, J. P. Nataro, R. Edelman, D. Pickard, G. Dougan, S. N. Chatfield, and M. M. Levine. 1997. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect. Immun. 65:452-456.
40. Tormo, A., M. Almiron, and R. Kolter. 1990. surA, an Escherichia coli gene essential for survival in stationary phase. J. Bacteriol. 172:4339-4347.
41. Tsai, C. M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Ann. Biochem. 119:115-119.
42. Valentine, P. J., B. P. Devore, and F. Heffron. 1998. Identification of three highly attenuated Salmonella typhimurium mutants that are more immunogenic and protective in mice than in a prototypical aroA mutant. Infect. Immun. 66:3378-3383.
43. Vancott, J. L., H. F. Staats, D. W. Pascual, M. Roberts, S. N. Chatfield, M. Yamamoto, M. Coste, P. B. Carter, H. Kiyono, and J. R. McGhee. 1996. Regulation of mucosal and systemic antibody responses by T helper subsets, macrophages, and derived cytokines following oral immunisation with live recombinant Salmonella. J. Immunol. 156:1504-1514.